Interaction between the Adhesion Receptor, CD44, and the Oncogene Product, p185 , Promotes Human Ovarian Tumor Cell Activation
Open Access
- 1 October 1997
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (44) , 27913-27918
- https://doi.org/10.1074/jbc.272.44.27913
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Cell Adhesion Molecule, GP116, Is a New CD44 Variant (ex14/v10) Involved in Hyaluronic Acid Binding and Endothelial Cell ProliferationJournal of Biological Chemistry, 1996
- A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid.The Journal of Experimental Medicine, 1996
- Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasisJournal of Neuro-Oncology, 1995
- New CD44 splice variants associated with human breast cancersJournal of Cellular Physiology, 1995
- Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.The Journal of cell biology, 1994
- Expression of CD44R1 adhesion molecule in colon carcinomas and metastasesThe Lancet, 1993
- Hyaluronan-binding protein in endothelial cell morphogenesis.The Journal of cell biology, 1992
- Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin.The Journal of cell biology, 1992
- Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancerCancer Letters, 1992
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986